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Abstract: Non-PH parametric survival modelling is developed within the frame-
work of the multiple logistic function. The family considered comprises three basic
models: (a) a PH model, (b) an accelerated life model and (c) a model which is
non-proportional hazards and non-accelerated life. The family is generalised by
means of a Gamma frailty extension which is shown to accommodate crossing haz-
ards data. These extensions lead naturally to the concept of a Multi-Parameter
Regression model described by Burke and MacKenzie (2016). The new models
are used to analyse two sets of survival data and the advantages of the methods
are discussed.
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2 Introduction
MacKenzie (1996) introduced a family of survival models based on the
multiple logistic function. The generalised time dependent logistic family
(GTDL) comprised three models (a) a PH model, (b) an accelerated life
(AL) model and (c) a model which is non-PH and non-AL. Development
was focussed on model (c), designated the GTDL model, and a Gamma
extension demonstrated its ability to deal with crossing hazards survival
data (MacKenzie and Ha, 2007). This example involved the creation of a
covariate dependent shape parameter. Accordingly, the idea of modelling
the shape parameter more generally intrudes and this has motivated the
development of multi-parameter regression survival models (MPR models)
(Burke and MacKenzie, 2013, 2016). We trace these methodological de-
velopments and illustrate the main ideas using a non-PH Weibull MPR
model.
3 The GTDL family
The GTDL family was predicated on the multiple logistic function and the
defining hazard functions of the three models in the family areas follows:
2 Non-PH parametric survival
(a) The GTDL PH model
λ(t;x) = pi(tα+ γ) exp(x′β) (1)
(b) The GTDL AL Model
λ(t;x) = λφpi(αφt) (2)
(c) The GTDL model
This model is not PH and not AL
λ(t;x) = λ0pi(tα+ γ
∗) (3)
In the models above pi(s) = exp(s)/[1 + exp(s)], λ0 > 0 and λ > 0 are
scalars, φ = exp(x′β) and γ∗ = x′β. An intercept term is included in the
linear predictor, γ∗, for model (c), but not in the other two models.
4 Frailty Extensions
Standard arguments involving the multiplicative random effect, ui, on the
hazard function yields, the general formulae for the marginal survivor and
hazard functions
Sm(t) = L[Λ(t)] = [1 + φΛ(t)]−1/φ, (4)
and
λm(t) = λ(t)
−L′[Λ(t)]
L[Λ(t)] =
λ(t)
1 + φΛ(t)
, (5)
respectively. Here S(t),Λ(t) and λ(t) are the basic survival quantities.
Moreover, L[Λ(t)] is the Laplace transform and U is the random effect
with density g(u) = [φ
1
φΓ(1/φ)]−1u
1
φ−1 exp(−u/φ) with E(U) = 1 and
V (U) = φ. In the main paper we use these formulae to generalise the three
models in the family and analyse the lung cancer data.
5 MPR modelling
MPR survival models model the scale and shape parameters simultaneously
as a function of covariates. We develop the Non-PH MPR Weibull model
which is used (below) to fit the lung cancer data. The hazard function is
given by
λ(t;x, z) = exp(x′β) exp(z′α)texp(z
′α)−1 (6)
where the Weibull hazard is λ(t) = λγtγ−1 (λ > 0, γ > 0) and the MPR
specification is
logλ = x′β (scale) logγ = z′α (shape)
note that x and z may contain the same covariates.
MacKenzie et al. 3
TABLE 1. Models fitted and their marginal mles & (s.e.)
Model αˆ0 αˆ1 βˆ0 βˆ1 σˆ
2 ˆ`
Cox - - - -0.106 - -307.47
- - - (0.223) -
Cox GF - - - -1.146 1.717 -306.50
- - - (0.675) (1.024)
TDL -0.832 -0.094 1.494 -1.380 - -132.55
(0.242) (0.192) (0.666) (0.822) -
GTDL GF -0.789 3.499 2.380 -4.612 0.400 -127.89
(0.326) (1.408) ( 1.413) (1.676) (0.176)
6 Applications
A classical motivating example is the crossing hazards data provided by
the Gastrointestinal Tumor Study Group (GTSG)(1982), reporting the ef-
fects of chemotherapy and combined chemotherapy and radiotherapy on
the survival times of gastric cancer patients.
The results of fitting several models is shown in Table 1. The most suc-
cessful model is the GTDL Gamma frailty model involving separate shape
parameters for the two groups. The other models (PH and non-PH) shown
in the table are not successful. This shows that having covariate dependent
shape parameters is sometimes useful.
We turn now to analyse the Lung Cancer data set.This was a multi-source
population study of 855 incident cases in Northern Ireland diagnosed be-
tween Oct. 1st 1991 and Sept. 30th 1992. The patients were followed for
c18 months and their survival time was computed as the time from di-
agnosis to death or censoring. Some 693 (77%) patients had died by the
censoring date (30th May, 1993).The influence of 9 covariates were anal-
ysed: Age, Sex, Treatment, WHO Status, Cell type, Sodium level, Albumen
level, Metastases and Smoking category.
The results are shown in Table 2. The presence of a β indicates a statisti-
cally significant covariate in the scale parameter while the presence of an α
indicates that the covariate is statistically significant in the shape param-
eter. In the PH model the shape parameter is a constant, γ. The presence
of an α also indicates that the covariate is formally non-PH. From the AIC
information, the superiority of the non-PH MPR model is apparent, even
though it fits more parameters.
4 Non-PH parametric survival
TABLE 2. Multi-factor MPR model for scale and shape
Covariate PH Weibull MPR Weibull
Treatment β β, α
Age group - -
WHO Status β β
Sex - -
Smoker β α
Cell Type β β
Metastases β β, α
Sodium β β
Albumen β β, α
AIC 3723.1 3679.7
∆-AIC 43.4 0.0
dim(θ) 22 30
7 Discussion
The GTDL family is of course not the only way to model non-PH data but
it was the use of a member of this family in the crossing hazards example
that led, in part, to the broader idea of modelling the shape parameter sym-
metrically with the usual scale parameter in survival distributions. This
highlights both the importance of the frailty concept and the MPR ap-
proach. In further work we have demonstrated that, unlike the lung cancer
data analysed here, both concepts can be required together which suggests
that the MPR model captures a form of time dependence which classical
frailty models cannot.
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